Oak Ridge Financial Services, Inc. Announces First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
36
Oak Ridge Financial Services, Inc. Announces First Quarter 2017 Earnings

OAK RIDGE, N.C., April 25, 2017 (GLOBE NEWSWIRE) -- Oak Ridge Financial Services, Inc. (“Oak Ridge”; the “Company”) (OTCPink:BKOR), the parent company of Bank of Oak Ridge (the “Bank”), announced unaudited financial results for the first quarter of 2017 today.

First Quarter 2017 Highlights

  • Net income available to common stockholders increased $187,000, or 42.0%, to $632,000 in 2017, compared to $445,000 in 2016  
  • Basic and diluted earnings per share of $0.26 for the three months ended March 31, 2017, up 6 cents, or 30.0%, from $0.20 for the same period in 2016
  • Return on average common stockholders’ equity 9.21% for the three months ended March 31, 2017, compared to 6.99% for the same period in 2016
  • Period end loans of $314.8 million, up 2.7% (11.0% annualized) from December 31, 2016
  • Period end deposits of $328.3 million, down 0.4% (1.5% annualized) from December 31, 2016
  • Period end noninterest-bearing deposits of $53.4 million, up 12.5% (50.7% annualized) from December 31, 2016
  • Nonperforming assets of $3.4 million, down from $3.5 million at December 31, 2016
  • Repurchase of 23,000 shares of common stock under the Company’s repurchase plan implemented in late 2016

Tom Wayne, President and Chief Financial Officer, reported, “I am very pleased with the Bank’s performance in the first quarter of 2017. Our net income and net income available to common stockholders increased significantly from 2016 to 2017, and we saw strong growth on the asset and liability sides of the balance sheet. It was also nice to see our noninterest expense and our efficiency ratio decline year over year, since growth combined with expense management is a focus of ours for 2017. I am thankful to our dedicated employees, the Board of Directors, and our clients for their support.”

Bank of Oak Ridge’s capital ratios remain strong and exceed all regulatory requirements at March 31, 2017. The Company’s stockholders’ equity was 7.0% of total assets as of March 31, 2017 and December 31, 2016. Tangible book value per common share was $11.77 as of March 31, 2017, compared to $11.37 as of December 31, 2016.

Net interest income was $3.4 million for the three months ended March 31, 2017, which was a small increase from $3.3 million during the same period in 2016. Total interest and dividend income increased approximately $131 thousand from 2016 to 2017, with increases in loan interest and fees of $215 thousand offset by decreases in interest on investment securities of $96 thousand during the same period of time. The increase in loan interest and fees was mostly due to increases in loan balances from 2016 to 2017, while the decrease in interest on investment securities was due to a decline in both investment securities balances and investment securities book yields from 2016 to 2017. Total interest expense increased $95 thousand from 2016 to 2017, with the decrease in interest expense on deposits of $41 thousand offset by an increase in interest expense on short-term and long-term debt of $135 thousand. The increase in interest expense on short-term and long-term debt is mostly due to interest expense in 2017 on $5.6 million in subordinated debentures issued on June 29, 2016. These subordinated debentures were used to redeem $5.2 million in Series A Preferred Stock on June 30, 2016, so most of the increase in interest expense on short-term and long-term debt in 2017 was offset by the lack of preferred dividends during the same period of time. The subordinated debentures issued on June 29, 2016 have an interest rate of 7%, while the Series A preferred stock redeemed on June 30, 2016 had a dividend rate of 9%. Interest expense on the debentures is deductible while dividend payments on the Series A preferred stock were non-deductible.

The Company recorded provision expense of $65,000 for 2017, compared $75,000 for 2016. The allowance for loan losses as a percentage of total loans was 1.19% at March 31, 2017 compared to 1.20% at December 31, 2016. Nonperforming assets ($3.3 million of nonperforming loans and $65,000 of other real estate owned) represented 0.85% of total assets at March 31, 2017, compared to 0.89% at December 31, 2016.

Noninterest income totaled $585,000 in 2017, compared with $608,000 in 2016, a decrease of $23,000 or 3.8%. The biggest noninterest income category contributing to the decline was a decrease in service charges on deposit accounts of $30,000 from 2017 to 2016. Other smaller increases and decreases contributed to the overall net decrease.

Noninterest expense totaled $3.0 million in 2017 and was relatively unchanged from $3.1 million in 2016.

About Oak Ridge Financial Services, Inc. Oak Ridge Financial Services, Inc. (OTCPink:BKOR) is the holding company for Bank of Oak Ridge. Bank of Oak Ridge is an employee owned community bank with a mission to provide Banking as It Should Be® by delivering personal attention and convenience for every client. Bank of Oak Ridge has been named Best Bank in the Triad five years in a row, one of the Triad’s Healthiest Employers and Top Workplaces, and winner of the Better Business Bureau’s Torch award for ethics in 2016.  We offer a complete range of banking services for individuals and businesses. Bank of Oak Ridge is a Member of the FDIC and an Equal Housing Lender.

Banking Services | ATM Usage Worldwide | Mobile Banking | Online Billpay | Remote Deposit | Checking | Savings | Mortgage | Insurance | Lending | Wealth Management

Visit Us | To learn more, visit us during our extended weekday and Saturday hours at one of our convenient locations in Greensboro, Summerfield and Oak Ridge, North Carolina, or call 336.644.9944, or online at www.BankofOakRidge.com . 

Forward-looking Information This form contains certain forward-looking statements with respect to the financial condition, results of operations and business of the Company.  These forward-looking statements involve risks and uncertainties and are based on the beliefs and assumptions of management of the Company and on the information available to management at the time that these disclosures were prepared. These statements can be identified by the use of words like “expect,” “anticipate,” “estimate” and “believe,” variations of these words and other similar expressions.  Readers should not place undue reliance on forward-looking statements as a number of important factors could cause actual results to differ materially from those in the forward-looking statements.  Factors that could cause actual results to differ materially include, but are not limited to, (1) competition in the Company’s markets, (2) changes in the interest rate environment, (3) general national, regional or local economic conditions may be less favorable than expected, resulting in, among other things, a deterioration in credit quality and the possible impairment of collectability of loans, (4) legislative or regulatory changes, including changes in accounting standards, (5) significant changes in the federal and state legal and regulatory environment and tax laws, (6) the impact of changes in monetary and fiscal policies, laws, rules and regulations and (7) other risks and factors identified in the Company’s other filings with the Federal Deposit Insurance Corporation.  The Company undertakes no obligation to update any forward-looking statements.

Oak Ridge Financial Services, Inc. Consolidated Balance Sheets March 31, 2017 (unaudited) and December 31, 2016 (audited) (Dollars in thousands)    
     
  March 31, 2017   December 31, 2016  
Assets    
     
Cash and due from banks $ 8,037 $ 7,718
Interest-bearing deposits with banks    12,325    10,626
Federal Funds sold    2,383    1,203
Total cash and cash equivalents    22,745    19,547
Securities available-for-sale    42,854    44,563
Securities held-to-maturity (fair values of $1,446 in 2017 and $1,520 in 2016)    1,328    1,397
Federal Home Loan Bank Stock, at cost    1,260    811
Loans, net of allowance for loan losses of $3,738 in 2017 and $3,678 in 2016    311,056    302,798
Property and equipment, net    8,674    8,795
Foreclosed assets    65    4
Accrued interest receivable    1,188    1,272
Bank owned life insurance    5,560    5,536
Other assets    3,266    3,086
      Total assets $ 397,996 $ 387,809
     
     
Liabilities and Stockholders’ Equity    
     
Liabilities    
Deposits:    
  Noninterest-bearing $ 53,360 $ 47,426
  Interest-bearing    274,960    282,148
      Total deposits    328,320    329,574
Short-term borrowings    21,500    11,500
Long-term borrowings    1,375    1,500
Junior subordinated notes related to trust preferred securities    8,248    8,248
Subordinated debentures    5,531    5,526
Accrued interest payable    115    98
Other liabilities    5,088    4,227
      Total liabilities    370,177    360,673
     
     
Stockholders’ equity    
Common stock, no par value; 50,000,000 shares authorized; 2,363,514 and 2,386,514 issued and outstanding in 2017 and 2016, respectively    19,928    20,064
Retained earnings    7,296    6,664
Accumulated other comprehensive income    595    408
      Total stockholders’ equity    27,819    27,136
      Total liabilities and stockholders’ equity $ 397,996 $ 387,809
Oak Ridge Financial Services, Inc. Consolidated Statements of Income (Unaudited) For the three months ended March 31, 2017 and 2016 (Dollars in thousands except per share data)          
           
    2017     2016    
Interest and dividend income    
Loans and fees on loans $    3,662 $ 3,447  
Interest on deposits in banks   23    15  
Federal Home Loan Bank stock dividends   8    5  
Taxable investment securities   292    388  
      Total interest and dividend income   3,985    3,854  
     
Interest expense    
Deposits   426    467  
Short-term and long-term debt   202    67  
      Total interest expense   628    533  
      Net interest income   3,357    3,321  
           
Provision for loan losses     65     75  
      Net interest income after provision for loan losses   3,292    3,246  
     
Noninterest income    
Service charges on deposit accounts   142   171  
Gain on sale of mortgage loans   14   12  
Investment commissions   20   2  
Insurance commissions   66   48  
Fee income from accounts receivable financing   43   58  
Debit card interchange income   203   221  
Income earned on bank owned life insurance   24   26  
Other service charges and fees   73   70  
      Total noninterest income   585   608  
     
Noninterest expense    
Salaries   1,502     1,516  
Employee benefits   173     217  
Occupancy   212     208  
Equipment   129     153  
Loss on sale of property and equipment   -   1  
Data and item processing   404     380  
Professional and advertising   190     181  
Stationary and supplies   48     65  
Net cost of foreclosed assets   -   13  
Impairment loss on securities   5   7  
Telecommunications   107     102  
FDIC assessment   56     57  
Accounts receivable financing   15   17  
Other expense   190   167  
      Total noninterest expense   3,031   3,084  
Income before income taxes   846   770  
Income tax expense   214   208  
     
Net income $    632 $  562  
Preferred stock dividends      -    (117 )
     
Income available to common stockholders $    632 $    445  
Basic income per common share $   0.26 $   0.20  
Diluted income per common share $    0.26 $   0.20  
Basic weighted average shares outstanding   2,387,954   2,270,397  
Diluted weighted average shares outstanding   2,398,997   2,281,439  
Oak Ridge Financial Services, Inc. Selected Quarterly Financial Ratios (unaudited)
 
Selected Financial Data March 31, 2017 December 31, 2016 September 30, 2016 June 30, 2016 March 31, 2016 December 31, 2015
Return on average common stockholders' equity 1   9.21 %   8.89 %   10.30 %   9.61 %   6.99 %   7.52 %
Tangible book value per share $ 11.77   $ 11.37   $ 11.56   $ 11.37   $ 11.26   $ 10.86  
Return on average assets 1   0.65 %   0.64 %   0.76 %   0.81 %   0.62 %   0.64 %
Net interest margin 1   3.67 %   3.83 %   3.77 %   3.81 %   3.88 %   3.96 %
Net interest income to average assets 1   3.47 %   3.51 %   3.54 %   3.65 %   3.67 %   3.69 %
Efficiency ratio   76.1 %   79.1 %   77.6 %   77.3 %   78.4 %   76.8 %
Nonperforming assets to total assets   0.85 %   0.89 %   0.90 %   0.82 %   0.83 %   0.85 %
                                     
1 Annualized                                    

Thomas W. Wayne, President and CFO Phone: 336-644-9944

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading